Amin Rakesh, Widmer Barry, Prevost A Toby, Schwarze Phillip, Cooper Jason, Edge Julie, Marcovecchio Loredana, Neil Andrew, Dalton R Neil, Dunger David B
University Department of Paediatrics, Addenbrooke's Hospital, Cambridge CB2 0QQ.
BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.
To describe independent predictors for the development of microalbuminuria and progression to macroalbuminuria in those with childhood onset type 1 diabetes.
Prospective observational study with follow-up for 9.8 (SD 3.8) years.
Oxford regional prospective study.
527 participants with a diagnosis of type 1 diabetes at mean age 8.8 (SD 4.0) years.
Annual measurement of glycated haemoglobin (HbA1c) and assessment of urinary albumin:creatinine ratio.
Cumulative prevalence of microalbuminuria was 25.7% (95% confidence interval 21.3% to 30.1%) after 10 years of diabetes and 50.7% (40.5% to 60.9%) after 19 years of diabetes and 5182 patient years of follow-up. The only modifiable adjusted predictor for microalbuminuria was high HbA1c concentrations (hazard ratio per 1% rise in HbA1c 1.39, 1.27 to 1.52). Blood pressure and history of smoking were not predictors. Microalbuminuria was persistent in 48% of patients. Cumulative prevalence of progression from microalbuminuria to macroalbuminuria was 13.9% (12.9% to 14.9%); progression occurred at a mean age of 18.5 (5.8) years. Although the sample size was small, modifiable predictors of macroalbuminuria were higher HbA(1c) levels and both persistent and intermittent microalbuminuria (hazard ratios 1.42 (1.22 to 1.78), 27.72 (7.99 to 96.12), and 8.76 (2.44 to 31.44), respectively).
In childhood onset type 1 diabetes, the only modifiable predictors were poor glycaemic control for the development of microalbuminuria and poor control and microalbuminuria (both persistent and intermittent) for progression to macroalbuminuria. Risk for macroalbuminuria is similar to that observed in cohorts with adult onset disease but as it occurs in young adult life early intervention in normotensive adolescents might be needed to improve prognosis.
描述儿童期发病的1型糖尿病患者发生微量白蛋白尿及进展为大量白蛋白尿的独立预测因素。
前瞻性观察性研究,随访9.8(标准差3.8)年。
牛津地区前瞻性研究。
527例平均年龄8.8(标准差4.0)岁时被诊断为1型糖尿病的患者。
每年测定糖化血红蛋白(HbA1c)并评估尿白蛋白:肌酐比值。
糖尿病病程10年后微量白蛋白尿的累积患病率为25.7%(95%置信区间21.3%至30.1%),糖尿病病程19年后及5182患者年随访后为50.7%(40.5%至60.9%)。微量白蛋白尿唯一可改变的校正预测因素是高HbA1c浓度(HbA1c每升高1%的风险比为1.39,1.27至1.52)。血压和吸烟史不是预测因素。48%的患者微量白蛋白尿持续存在。从微量白蛋白尿进展为大量白蛋白尿的累积患病率为13.9%(12.9%至14.9%);进展发生的平均年龄为18.5(5.8)岁。尽管样本量较小,但大量白蛋白尿的可改变预测因素是较高的HbA1c水平以及持续性和间歇性微量白蛋白尿(风险比分别为1.42(1.22至1.78)、27.72(7.99至96.12)和8.76(2.44至31.44))。
在儿童期发病的1型糖尿病中,唯一可改变的预测因素是血糖控制不佳导致微量白蛋白尿的发生,以及控制不佳和微量白蛋白尿(持续性和间歇性)导致进展为大量白蛋白尿。大量白蛋白尿的风险与成年发病队列中观察到的风险相似,但由于其发生在年轻成年期,可能需要对血压正常的青少年进行早期干预以改善预后。